Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. - Wikidata - awgldk - TriplyDB

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

http://www.wikidata.org/entity/Q36709153

about

Novel approaches for treating hypertension Heart failure-potential new targets for therapy.Targeting vasoactive peptides for managing calcific aortic valve disease.Angiotensin-Neprilysin Inhibition as a Paradigm for All?Long-term neprilysin inhibition - implications for ARNIs.Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy.Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan.Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A.Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition.MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells.Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment

P2860

Q37620461-32333906-1EB8-4E6F-8CB7-4946CA650120 Q38882867-EF945051-BB49-474D-9CD4-4DB9A3CD81ED Q38943935-F101B959-52DC-4581-8FC5-AD7B616BF6C4 Q38982213-6D17C9F6-2477-4552-892F-F5A42034EDCE Q39038686-35677804-FF55-4412-856A-2EE12C19FF06 Q42407960-F70EF100-ACBC-48BF-9540-5A4EDE4441A6 Q47652218-52A7191D-BF16-40B9-BE42-9F0FF85EBF0E Q47898606-5D4D40FC-93DF-4048-B6EB-DA5230112497 Q49481766-0C89B306-ADDF-429A-B1EA-A3A8BC331F4F Q49914014-67E807FA-E172-40A8-8A61-4BFA900E5B44 Q51053075-BCA644CF-962E-45EA-BC2E-36F453D80D79 Q51687884-EA13014A-7BBE-491B-99B1-FFCEAABC778E Q54968441-B5FD42A6-C339-46E5-942A-CD7C40FAE21E Q58798977-606AC346-49B8-4641-B532-AFF24CBB935B

P2860

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

http://www.wikidata.org/entity/Q36709153

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@ast

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@en

type

label

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@ast

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@en

prefLabel

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@ast

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@en

P1433

Q36709153-30670AA6-ECAA-49C1-BE7B-E1500F29455F

P1476

Q36709153-7C1B8EE9-600F-4938-AAB5-6CC698B07859

P2093

Q36709153-0FE30FA4-2071-4417-811C-024F38768C88

Q36709153-E2A3BF2E-82B3-4C31-80EF-603671840DAE

P2860

Q36709153-006F67C6-8FE3-4D2F-8311-A6739A620545

Q36709153-01860A50-4BF8-44B7-B72F-91BDCBFDE3C2

Q36709153-0511AE3F-BCE9-4568-8465-CCFD54104DF8

Q36709153-13EAAA8B-7943-499D-98B7-D032E11EE9CC

Q36709153-1A0F4F9C-3297-4AF5-9C6B-81ED03DA0778

Q36709153-23D49F8B-42EA-46AB-A856-E5F9C4773FD5

Q36709153-254D73C9-5FD8-4721-ABBC-8ABABCC64FCF

Q36709153-26FBC12D-DC7C-4B31-A643-F9EFE1CCC193

Q36709153-2C662BF3-A38C-4CC8-95B6-D3629B9F06DA

Q36709153-371CE842-7C44-4F2E-B89F-73E52C17E58B

P304

Q36709153-60FA6F97-0053-4D9A-AADA-182FE6FC9236

P31

Q36709153-DBFDF378-396C-477D-AA49-023B7EE44E5B

P356

Q36709153-5F32C52A-D565-49C2-991A-A890823B787B

P407

Q36709153-52EF3F9F-30E9-47A9-96F4-A2645116EDB9

P433

Q36709153-0764D72F-FA43-4276-9A53-32B2B2071153

P478

Q36709153-CE5140F0-6BA1-4D93-9C16-32CA070BB5C7

P577

Q36709153-47861E95-02FB-4B27-B01B-962C937AF8FF

P698

Q36709153-DEA32C8B-CC36-4106-97DA-7887CEC9D084

P932

Q36709153-172087B1-0ECA-4FF3-8ED2-C02B54A9F021

P356

CIRCULATIONAHA.115.018622

P1433

P1476

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

@en

P2093

Nancy J Brown

http://www.w3.org/2001/XMLSchema#string

Scott A Hubers

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

Effect of nesiritide in patients with acute decompensated heart failure

Angiotensin-neprilysin inhibition versus enalapril in heart failure

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Angiotensin II type 1 receptor blockers.

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.

P304

1115-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.115.018622

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26976916

http://www.w3.org/2001/XMLSchema#string

P932

4800749

http://www.w3.org/2001/XMLSchema#string